Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.86.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JN.1.34NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.34NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
HK.3.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.3.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26650.4US
JN.1.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.6NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JG.3.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JG.3.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JN.1.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.4NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JN.1.22NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.22NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JN.1.15NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.15NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
KP.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.5NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
XDP.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDP.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
KP.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JN.1.31NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.31NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JN.1.11.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.11.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JD.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JD.1.1.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
KS.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KS.1.3NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
MK.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
MK.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
KP.4.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.4.1.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
KP.4.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.4.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
LB.1.7.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LB.1.7.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
XBL.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBL.3.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
XBB.2.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.4NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
XBB.1.28.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.28.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
GA.6.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GA.6.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
XBB.1.5.61NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.61NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
FR.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FR.1.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
MH.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used